Abstract:The goal to attenuate inflammation without inducing generalized immunosuppression has focused the attention on chemokines, a family of chemotactic peptides that regulate the leukocyte traffick into tissues. However, the development of drugs that block ckemokine activity may be hampered by the observation that some chemokines display pleiotropic biologic functions. For example, the chemokines CXCL9/Mig, CXCL10/IP-10, and CXCL11/I-TAC exhibit the ability to recruit different leukocytes subsets, the capacity to induce the proliferation of vascular pericytes as well as powerful anti-tumor effects, which are mediated by a common receptor, named CXCR3. Because of their pleiotropic biologic effects, these chemokines have been proposed as possible therapeutic targets in cancer, allograft rejection, glomerulonephritis, diabetes, multiple sclerosis, and autoimmune disorders of the thyroid. The chemokine CXCL4/PF4 shares several activities with CXCL9, CXCL10, and CXCL11, including angiostatic effects, although its specific receptor has remained unknown for a long time. Recently, we provided evidence that the different functions of CXCL9, CXCL10, and CXCL11 on distinct cell types can be at least partly explained by the interaction of these chemokines with two distinct receptors. Indeed, in addition to the classic form of CXCR3 receptor, which we have renamed as CXCR3-A, a novel CXCR3 receptor variant (CXCR3-B) was identified, that not only mediates the angiostatic activity of CXCR3 ligands, but also acts as functional receptor for CXCL4. In this review, we focus on the accumulating evidence demonstrating the pivotal role of CXCR3-binding chemokines in several human diseases. Studies based on CXCR3 targeting have shown its importance in different pathologic conditions and orally active small molecules capable of inhibiting this receptor are now being developed in order to be tested for their activity in humans.

The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration

Pleiotropic Roles of CXCR4 in Wound Repair and Regeneration

Involvement of CXCR4 in Normal and Abnormal Development

Chemokine-chemokine Receptor Pathway As a Tumor Therapeutic Target: the Significance of SDF-1CXCR4 Pair

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

Effect of CXCR7 on Tumor Development,Angiogenesis and Immune Reaction

CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment

CXCR3-binding chemokines: novel multifunctional therapeutic targets

The Role of CXCR3 and Its Ligands in Cancer

The molecular mechanism of CXCR4/SDF-1 in tumor signal transduction

CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4

Chemokines, Chemokine Receptors and Hematopoiesis

CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks

CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer

Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer

The chemokine receptors CXCR4 and CXCR7 in cancer

CXCR7 in tumorigenesis and progression.

CXCR4: from B-cell development to B cell-mediated diseases

Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression